$70.95
+3.46 (+5.13%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+216.04%
YTD
+125.96%
Open$67.04
Previous Close$67.49
Day High$71.41
Day Low$66.75
52W High$93.61
52W Low$21.15
Volume—
Avg Volume1.07M
Market Cap5.85B
P/E Ratio42.17
EPS$1.39
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$37.31
Above
SMA 200
$25.48
Above
RSI (14)
31.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
15 analysts
Price Target
-39.2% upside
Current
$70.95
$70.95
Target
$43.17
$43.17
$30.71
$43.17 avg
$51.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 160.79M | 12.24M | 783.80M |
| Net Income | -69,999,450 | -102,665,771 | 150.56M |
| Profit Margin | -43.5% | -885.1% | 19.2% |
| EBITDA | -52,152,168 | -104,281,125 | 266.89M |
| Free Cash Flow | — | — | 76.52M |
| Rev Growth | +115.0% | +2.9% | +0.6% |
| Debt/Equity | 1.49 | 1.49 | 0.76 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,181.89 | +2.68% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $270.68 | +0.56% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $147.98 | -0.07% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.41 | +0.82% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.50 | +0.57% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $70.27 | -1.87% | 11.5 | 30.15B |